We could not find any results for:
Make sure your spelling is correct or try broadening your search.
GSK PLC 03 May 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Sally Jackson b) Position/status SVP, Global...
GSK PLC 01 May 2024 GSK plc Total Voting Rights and Capital In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GSK plc (the 'Company...
GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance ...
GSK PLC 01 May 2024 GSK makes a strong start to 2024 with improving outlook for the year Broad-based performance drives sales, profits and earnings growth: • Total Q1 2024 sales £7.4...
GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence applic ...
GSK PLC 24 April 2024 Issued: 24 April 2024, London UK US FDA accepts for priority review GSK's application for an expanded indication of Jemperli (dostarlimab) plus chemotherapy to...
GSK PLC 19 April 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...
GSK PLC 17 April 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief Executive...
GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a for ...
GSK PLC 17 April 2024 Issued: 17 April 2024, London UK EAGLE-1 phase III data show potential for gepotidacin as a new oral treatment option for uncomplicated urogenital gonorrhoea (GC...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 95 | 5.79798596277 | 1638.5 | 1739.5 | 1634 | 5724166 | 1688.59647596 | DE |
4 | 121.5 | 7.53722084367 | 1612 | 1739.5 | 1575 | 5986230 | 1638.19281372 | DE |
12 | 74.9 | 4.51585674665 | 1658.6 | 1739.5 | 1575 | 7825029 | 1661.12478769 | DE |
26 | 334.1 | 23.8745176504 | 1399.4 | 1739.5 | 1379.6 | 7697356 | 1574.4219477 | DE |
52 | 276.1 | 18.944696034 | 1457.4 | 1739.5 | 1302.6 | 7423588 | 1497.82777515 | DE |
156 | 395.5 | 29.5590433483 | 1338 | 1824.4 | 1283.2 | 8570252 | 1512.06611032 | DE |
260 | 178.3 | 11.4647633745 | 1555.2 | 1857 | 1190.8 | 8871058 | 1525.05094154 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions